December 10, 2018

The New Criterion

Having been buoyed earlier on by some positive clinical trials – notably from HIV drug house Biotron (BIT, 20c), the ASX’s biotech sector is finishing the […]
December 10, 2018

Kavanagh

The chaotic end to the Parliamentary year in Canberra left a lot of financial legislation waiting for consideration and, with only relatively few sitting days until […]
December 3, 2018

The New Criterion

Vonex (VN8) 10c To Vonex chief Matt Fahey, the intensifying rollout of the National Broadband Network rivals the deregulation of the telecommunications sector in the 1990s […]
December 3, 2018

Kavanagh

A big concern for investors over the past year has been the slowing home loan market. A slowdown in mortgage lending is bad news for bank […]
November 26, 2018

Kavanagh

We have been reading a lot lately about the fall in the household savings ratio and the impact this might have on the economy. Consumers have […]